This patent covers the use of stromal cells for delivery of genes. Stromal cells can migrate systemically and when transfected with genes can serve as a stable source of protein production in a patient.
I wonder what the difference is between the stromal cells described in this patent and the mesenchymal stem cells covered by Osiris?
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.